ERK, STAT3, and p38 MAPK have also been found to regulate paclitaxel-induced chemosensitivity in many carcinomas, including lung cancer [31], gastric cancer [32], breast cancer [33,34], and ovarian cancer [35,36]. Here, STAT3 is linked to ovarian carcinoma.